Bruce G. Ward

2.8k total citations
57 papers, 2.3k citations indexed

About

Bruce G. Ward is a scholar working on Molecular Biology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bruce G. Ward has authored 57 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Reproductive Medicine and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bruce G. Ward's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Ovarian cancer diagnosis and treatment (17 papers) and Glycosylation and Glycoproteins Research (14 papers). Bruce G. Ward is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Ovarian cancer diagnosis and treatment (17 papers) and Glycosylation and Glycoproteins Research (14 papers). Bruce G. Ward collaborates with scholars based in Australia, United States and United Kingdom. Bruce G. Ward's co-authors include W. Kim Halford, Jennifer L. Scott, Michael A. McGuckin, Michael D. Waterfield, William J. Gullick, Nigel Whittle, Peter L. Devine, Terry Hurst, Christopher Bain and Victor Siskind and has published in prestigious journals such as Cancer, Journal of Consulting and Clinical Psychology and Biochemical and Biophysical Research Communications.

In The Last Decade

Bruce G. Ward

57 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce G. Ward Australia 26 791 720 700 389 319 57 2.3k
R K Dodge United States 24 611 0.8× 969 1.3× 826 1.2× 409 1.1× 299 0.9× 38 2.6k
Harald Sommer Germany 29 455 0.6× 2.0k 2.8× 609 0.9× 420 1.1× 380 1.2× 69 3.0k
Benjamin Piura Israel 29 1.0k 1.3× 770 1.1× 460 0.7× 111 0.3× 301 0.9× 163 2.9k
Ju‐Won Roh South Korea 26 389 0.5× 612 0.8× 673 1.0× 168 0.4× 118 0.4× 58 2.2k
Dianne Miller Canada 33 1.9k 2.4× 878 1.2× 734 1.0× 175 0.4× 256 0.8× 79 3.7k
Masami Fujita Japan 35 889 1.1× 809 1.1× 1.2k 1.7× 80 0.2× 276 0.9× 121 3.8k
Anna Myriam Perrone Italy 26 912 1.2× 346 0.5× 429 0.6× 210 0.5× 195 0.6× 165 2.4k
David Oram United Kingdom 28 2.0k 2.5× 486 0.7× 436 0.6× 212 0.5× 159 0.5× 64 3.3k
Andrea R. Hagemann United States 23 602 0.8× 718 1.0× 370 0.5× 78 0.2× 429 1.3× 119 2.0k
Michael Conner United States 23 465 0.6× 521 0.7× 489 0.7× 57 0.1× 267 0.8× 72 1.9k

Countries citing papers authored by Bruce G. Ward

Since Specialization
Citations

This map shows the geographic impact of Bruce G. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce G. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce G. Ward more than expected).

Fields of papers citing papers by Bruce G. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce G. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce G. Ward. The network helps show where Bruce G. Ward may publish in the future.

Co-authorship network of co-authors of Bruce G. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce G. Ward. A scholar is included among the top collaborators of Bruce G. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce G. Ward. Bruce G. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scott, Jennifer L., W. Kim Halford, & Bruce G. Ward. (2004). United We Stand? The Effects of a Couple-Coping Intervention on Adjustment to Early Stage Breast or Gynecological Cancer.. Journal of Consulting and Clinical Psychology. 72(6). 1122–1135. 239 indexed citations
2.
Ward, Bruce G., et al.. (2003). Outpatient management of abnormal smears. Australian and New Zealand Journal of Obstetrics and Gynaecology. 43(1). 50–53. 1 indexed citations
3.
Preyer, Oliver, Andreas Obermair, Elisabeth Formann, et al.. (2002). The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement on Survival in Patients with Stage IIIA Uterine Cancer. Gynecologic Oncology. 86(3). 269–273. 23 indexed citations
4.
Obermair, Andreas, Bernd Schmid, Leisl Packer, et al.. (2002). Expression of MUC1 splice variants in benign and malignant ovarian tumours. International Journal of Cancer. 100(2). 166–171. 36 indexed citations
5.
Low, Jeffrey, et al.. (1999). Fertility and Ovarian Function After Conservative Surgery for Germ Cell Tumours of the Ovary. Australian and New Zealand Journal of Obstetrics and Gynaecology. 39(2). 243–245. 45 indexed citations
6.
Wright, K, Peter J. Wilson, Sarah J. Morland, et al.. (1999). ?-Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. International Journal of Cancer. 82(5). 625–629. 111 indexed citations
7.
Ward, Bruce G. & Sujata Pradhan. (1998). Comparison of Low Molecular Weight Heparin (Fragmin) With Sodium Heparin for Prophylaxis Against Postoperative Thrombosis in Women Undergoing Major Gynaecological Surgery. Australian and New Zealand Journal of Obstetrics and Gynaecology. 38(1). 91–92. 35 indexed citations
8.
Hurst, Terry, et al.. (1998). No Evidence for Microsatellite Instability from Allelotype Analysis of Benign and Low Malignant Potential Ovarian Neoplasms. Gynecologic Oncology. 69(3). 210–213. 22 indexed citations
9.
Devine, Peter L., et al.. (1998). Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women. Cancer Immunology Immunotherapy. 46(5). 245–252. 54 indexed citations
10.
Green, Adèle C., David M. Purdie, Christopher Bain, et al.. (1997). Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. International Journal of Cancer. 71(6). 948–951. 127 indexed citations
11.
Green, Adèle C., David M. Purdie, Christopher Bain, et al.. (1997). Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. International Journal of Cancer. 71(6). 948–951. 12 indexed citations
12.
Chenevix‐Trench, Georgia, Terry Hurst, David Purdie, et al.. (1997). Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlations. Genes Chromosomes and Cancer. 18(2). 75–83. 44 indexed citations
13.
McGuckin, Michael A., Peter L. Devine, Louise E. Ramm, & Bruce G. Ward. (1994). Factors Effecting the Measurement of Tumor-Associated MUC1 Mucins in Serum. Tumor Biology. 15(1). 33–44. 23 indexed citations
14.
Ward, Bruce G., et al.. (1994). Randomized Prospective Intervention Study of Human Cervical Wart Virus Infection. Australian and New Zealand Journal of Obstetrics and Gynaecology. 34(2). 182–185. 3 indexed citations
15.
McGuckin, Michael A., et al.. (1993). Circulating tumour-associated mucin concentrations, determined by the CASA assay, in healthy women. Clinica Chimica Acta. 214(2). 139–151. 17 indexed citations
16.
17.
18.
Ward, Bruce G., et al.. (1987). Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts.. PubMed. 47(17). 4714–8. 33 indexed citations
19.
Ward, Bruce G., et al.. (1985). Libel and medicine.. BMJ. 290(6478). 1302–1302. 1 indexed citations
20.
Kerin, John F., et al.. (1983). Incidence of the luteinized unruptured follicle phenomenon in cycling women. Fertility and Sterility. 40(5). 620–626. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R K Dodge Breakdown of academic impact, for papers by Harald Sommer Breakdown of academic impact, for papers by Benjamin Piura Breakdown of academic impact, for papers by Ju‐Won Roh Breakdown of academic impact, for papers by Dianne Miller Breakdown of academic impact, for papers by Masami Fujita Breakdown of academic impact, for papers by Anna Myriam Perrone Breakdown of academic impact, for papers by David Oram Breakdown of academic impact, for papers by Andrea R. Hagemann Breakdown of academic impact, for papers by Michael Conner
Rankless by CCL
2026